© 2012 CareFusion Corporation or one of its subsidiaries. All rights reserved. 2 Forward-Looking Statements and Other Notices to Investors statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. The matters discussed in these forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. The most significant of these uncertainties are described in CareFusion’s Form 10-K, Form 10-Q and Form 8-K reports (including all amendments to those reports) and exhibits to those reports, and include (but are not limited to) the following: we may be unable to effectively enhance our existing products or introduce and market new products or may fail to keep pace with advances in technology; we are subject to complex and costly regulation; cost containment efforts of our customers, purchasing groups, third-party payers and governmental organizations could adversely affect our sales and profitability; current economic conditions have and may continue to adversely affect our results of operations and financial condition; we may be unable to realize any benefit from our cost reduction and restructuring efforts and our profitability may be hurt or our business otherwise might be adversely affected; we may be unable to protect our intellectual property rights or may infringe on the intellectual property rights of others; defects or failures associated with our products and/or our quality system could lead to the filing of adverse event reports, recalls or safety alerts and negative publicity and could subject us to regulatory actions; we are currently operating under an amended consent decree with the FDA and our failure to comply with the requirements of the amended consent decree may have an adverse effect on our business; and our success depends on our key personnel, and the loss of key personnel or the transition of key personnel, including our chief executive officer, could disrupt our business. This presentation reflects management’s views as of August 9, 2012. Except to the extent required by applicable law, we undertake no obligation to update or revise any forward-looking statement. The financial information included in this presentation includes non-GAAP financial measures. Reconciliations can be found on slides 12-18 of this presentation. In addition, definitions and reconciling information can be found on CareFusion’s website at under the Investors tab. Historically, we have provided non-GAAP financial measures that exclude items from our reported results primarily related to nonrecurring restructuring and acquisition integration charges, nonrecurring items related to the spinoff and nonrecurring tax items. As costs associated with the spinoff are substantially complete, our adjusted results will no longer exclude spinoff related charges and associated tax impacts. Going forward, we intend to provide non-GAAP financial measures that exclude from our reported results amounts associated with nonrecurring restructuring and acquisition integration charges, the amortization of acquired intangible assets, �� Commencing with the quarter ended September 30, 2011, CareFusion began reporting financial results based on its two new operating and reportable segments, Medical Systems and Procedural Solutions. The financial information contained in this presentation reflects these new segments, which replaced the Critical Care Technologies and Medical Technologies and Services segments under which the company had previously reported. The Medical Systems segment includes the company’s Dispensing Technologies, Infusion Systems and Respiratory Technologies business lines. The Procedural Solutions segment includes the company’s Infection Prevention, Medical Specialties and Specialty Disposables business lines. The company has separately provided summary historical financial data for the new reportable segments in a report on Previously reported results have been adjusted to reflect the reclassification of certain divested businesses as discontinued operations. The Nicolet, International Surgical Products (ISP), and Audiology businesses were divested in July 2012, April 2011, and October 2009, respectively. The financial information contained in this presentation reflects these reclassifications for each period presented. Non-GAAP Financial Measures: New Reporting Segments: Discontinued Operations: www.carefusion.com “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Form 8-K files with the Securities and Exchange Commission on November 2, 2011. and the tax effects of these items. This presentation contains forward-looking | 
